M&A Deal Summary

Sawai Pharmaceutical Acquires Upsher-Smith Laboratories - Generics Business

On April 20, 2017, Sawai Pharmaceutical acquired life science company Upsher-Smith Laboratories - Generics Business from Upsher-Smith Laboratories for 1.1B USD

Acquisition Highlights
  • This is Sawai Pharmaceutical’s 1st transaction in the Life Science sector.
  • This is Sawai Pharmaceutical’s largest (disclosed) transaction.
  • This is Sawai Pharmaceutical’s 1st transaction in the United States.
  • This is Sawai Pharmaceutical’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2017-04-20
Target Upsher-Smith Laboratories - Generics Business
Sector Life Science
Buyer(s) Sawai Pharmaceutical
Sellers(s) Upsher-Smith Laboratories
Deal Type Divestiture
Deal Value 1.1B USD

Target

Upsher-Smith Laboratories - Generics Business

Maple Grove, Minnesota, United States
Upsher-Smith Laboratories, Inc. - Generics Business is a manufacturer of generic products in Minnesota, United States.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sawai Pharmaceutical

Osaka, Japan
Category Company
Founded 1929
Sector Life Science
Employees1,490
DESCRIPTION

Sawai Pharmaceutical Co. Ltd. is a generic pharmaceuticals manufacturer. Sawai Pharmaceutical was founded in 1929 and is based in Osaka, Japan.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Upsher-Smith Laboratories

Maple Grove, Minnesota, United States
Category Company
Founded 1919
Sector Life Science
DESCRIPTION

Upsher-Smith Laboratories is a pharmaceutical company, that delivers quality therapies and solutions that measurably improve individuals’ lives. Upsher-Smith Laboratories is based in Maple Grove, Minnesota.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 2 of 2
State (Minnesota) 2 of 2
Country (United States) 2 of 2
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-19 AmLactin

Maple Grove, Minnesota, United States

AmLactin is a developer, manufacturer of skin care products including therapeutic moisturizers and conditioners.

Sell -
Mergr

Product

Company

Legal